<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="diseases of viral origin, research on parasitic diseases such as" exact="malaria" post="continues to remain critical and innovative methods are required"/>
 <result pre="complementary reviews on metal-based complexes tested against malaria. bioorganometallic chemistry" exact="malaria" post="Plasmodium falciparum platinum-group metals mechanism of action 1. Introduction"/>
 <result pre="these endeavours. The elimination of wildtype cases of the infectious" exact="viral disease," post="polio, which has been recently declared â€œeradicatedâ€� from the"/>
 <result pre="of infectious diseases [1]. Despite these successes, infectious diseases like" exact="malaria" post="remain prevalent and still burden the health-care sector and"/>
 <result pre="part to the emergence of new, tenacious strains of the" exact="malaria" post="parasite that are displaying resistance to current frontline drugs"/>
 <result pre="innovative drug candidates possessing novel mechanistic modalities unknown to the" exact="malaria" post="parasite to combat the development of clinical resistance. The"/>
 <result pre="platinum-based anticancer agent, cisplatin, which has had tremendous success within" exact="cancer" post="treatment regimens [7,8]. Concerning its pharmacological applications, platinum is"/>
 <result pre="cytotoxic agents, in the emerging field of photodynamic therapy, for" exact="cancer" post="treatment [16,17]. Likewise, the introduction of PGM moieties into"/>
 <result pre="strain and the chloroquine -resistant (CQR) Dd2 strain of the" exact="malaria" post="parasite, P. falciparum. Generally, the complexes exhibited activity in"/>
 <result pre="by the Dyson group, which showed antiproliferative efficacy against several" exact="cancer" post="cell-lines [27]. The multiple basic nitrogen atoms within the"/>
 <result pre="toward the CHO cell-line, and thus greater selectivity toward the" exact="malaria" post="parasite, with selectivity indices greater than or equal to"/>
 <result pre="of hemozoin synthesis, which is a pathway unique to the" exact="malaria" post="parasite and a crucial detoxification mechanism. 2.2. Quinoline-Triazole Ligands"/>
 <result pre="40â€&quot;41 [46]. Despite the complexes showing high selectivity for the" exact="malaria" post="parasites over the mammalian CHO cells, no significant improvement"/>
 <result pre="congeners. High selectivity indices of &amp;gt;10 were observed for the" exact="malaria" post="parasites over the mammalian cells for selected promising complexes"/>
 <result pre="undergoing reversible Fenton-type redox processes inside the DV of the" exact="malaria" post="parasite [62,63]. 4.2. Quinoline-Salicylaldiminato and Sulfadoxine Ligands In addition"/>
 <result pre="potent than the Ir(III) congeners with higher selectivity towards the" exact="malaria" post="parasites (NF54 and K1) over the mammalian CHO cells"/>
 <result pre="complexes have become versatile with great promise for utility in" exact="cancer" post="treatment, including light-activated cancer therapy and photodynamic therapy [68,69]."/>
 <result pre="with great promise for utility in cancer treatment, including light-activated" exact="cancer" post="therapy and photodynamic therapy [68,69]. The anticancer effects of"/>
 <result pre="their pioneering studies [85]. Like in cancer, palladium complexes in" exact="malaria" post="research have been explored in the literature with a"/>
 <result pre="potentially retain them in the active site of the targeted" exact="malaria" post="parasite (DV) (Figure 23) [90]. As previously discussed, the"/>
 <result pre="Plasmodial Heme Biocrystallisation Pathway During the blood stages of the" exact="malaria" post="parasiteâ€™s lifecycle, the Plasmodium species digests haemoglobin from the"/>
 <result pre="species, leading to its death. To counteract this effect, the" exact="malaria" post="parasite has developed a pathway that biocrystallizes free heme"/>
 <result pre="molecules into insoluble, non-toxic crystalline hemozoin, also known as the" exact="malaria" post="pigment. This takes place inside the parasiteâ€™s acidic DV"/>
 <result pre="possible chemotherapeutic agents, and this has been extensively studied in" exact="cancer" post="research of bioorganometallic complexes [105,106,107,108]. The binding affinity of"/>
 <result pre="the generation of organometallic chemotypes with good selectivity towards the" exact="malaria" post="parasites. To further illustrate this point, the authors tested"/>
 <result pre="in contemporary drug discovery and is showing encouraging results in" exact="cancer" post="research [112,113,114,115]. In particular, examples of PGM complexes bearing"/>
 <result pre="catalyse transfer hydrogenation associated with their antiproliferative activity [112,113,114,115]. In" exact="malaria" post="research, targeting biochemical processes by intracellular catalysis is still"/>
 <result pre="findings show that the strategy of disrupting biochemical processes in" exact="malaria" post="parasites via intracellular catalysis is a viable avenue for"/>
 <result pre="for candidates with unique modes of action unknown to the" exact="malaria" post="parasite. PGM complexes show promise in this regard as"/>
 <result pre="the ability to disrupt the heme detoxification pathway of the" exact="malaria" post="parasite as a mode of action, although this property"/>
 <result pre="Biol.202056232710.1016/j.cbpa.2019.10.00431759225 18.SÃ¡nchez-DelgadoR.A.AnzellottiA.Metal complexes as chemotherapeutic agents against tropical diseases: Trypanosomiasis," exact="malaria" post="and leishmaniasisMini Rev. Med. Chem.20044233014754440 19.BiotC.CastroW.BottÃ©C.Y.NavarroM.The therapeutic potential of"/>
 <result pre="complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum" exact="malaria" post="parasiteJ. Inorg. Biochem.201919116417310.1016/j.jinorgbio.2018.11.01830529881 27.SuW.LiY.LiP.Design of Ru-arene complexes for antitumor"/>
 <result pre="drugs and â€˜chloroquine resistance reversersâ€™ from the digestive vacuole in" exact="malaria" post="parasites with mutant PfCRTMol. Microbiol.2010771039105110.1111/j.1365-2958.2010.07272.x20598081 29.MelisD.R.BarnettC.B.WiesnerL.NordlanderE.SmithG.S.Quinoline-triazole half-sandwich iridium (III)"/>
 <result pre="drugsMetallomics2009145847010.1039/b904071d21305154 37.LiuJ.LaiH.XiongZ.ChenB.ChenT.Functionalization and cancer-targeting design of ruthenium complexes for precise" exact="cancer" post="therapyChem. Commun.2019559904991410.1039/C9CC04098F 38.SÃ¡nchez-DelgadoR.A.NavarroM.PÃ©rezH.UrbinaJ.A.Toward a novel metal-based chemotherapy against tropical"/>
 <result pre="action of cisplatin and its analoguesJ. Histochem. Cytochem.1993411053107310.1177/41.7.85150488515048 93.DasariS.TchounwouP.B.Cisplatin in" exact="cancer" post="therapy: Molecular mechanisms of actionEur. J. Pharmacol.201474036437810.1016/j.ejphar.2014.07.02525058905 94.HempelmannE.Hemozoin biocrystallization"/>
 <result pre="101.AravindL.IyerL.M.WellemsT.E.MillerL.H.Plasmodium biology: Genomic gleaningsCell200311577178510.1016/S0092-8674(03)01023-714697197 102.WoynarowskiJ.M.KrugliakM.GinsburgH.Pharmacogenomic analyses of targeting the AT-rich" exact="malaria" post="parasite genome with AT-specific alkylating drugsMol. Biochem. Parasitol.2007154708110.1016/j.molbiopara.2007.04.00917524501 103.WenzelN.I.ChavainN.WangY.FriebolinW.MaesL.PradinesB.LanzerM.YardleyV.BrunR.Herold-MendeC.Antimalarial"/>
 <result pre="catalytic metallodrugsChem. Rev.201911982986910.1021/acs.chemrev.8b0049330618246 112.CoverdaleJ.P.Romero-CanelÃ³nI.Sanchez-CanoC.ClarksonG.J.HabtemariamA.WillsM.SadlerP.J.Asymmetric transfer hydrogenation by synthetic catalysts in" exact="cancer" post="cellsNat. Chem.20181034710.1038/nchem.291829461524 113.BiancalanaL.AbdalghaniI.ChielliniF.ZacchiniS.PampaloniG.CrucianelliM.MarchettiF.Ruthenium Arene Complexes with Î±-Aminoacidato Ligands: New"/>
 <result pre="strains [45]. Figure 20 Next generation platinum(II) complexes approved for" exact="cancer" post="treatment [73,74,75]. Figure 21 Inorganic (80â€&quot;81) and organometallic (83â€&quot;84)"/>
</results>
